IDEAYA Biosciences, Inc. (IDYA) › Operating Cash FlowIDEAYA Biosciences, Inc. (IDYA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$12.22M2018: -$27.62M2019: -$39.31M2020: $55.46M2021: -$55.78M2022: -$87.17M2023: -$115.22M2024: -$247.58M2025: -$71.10M-$71.10M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$71.10M+71.3%2024-$247.58M-114.9%2023-$115.22M-32.2%2022-$87.17M-56.3%2021-$55.78M-200.6%2020$55.46M+241.1%2019-$39.31M-42.3%2018-$27.62M-125.9%2017-$12.22M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share